{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:59:11Z","timestamp":1778914751645,"version":"3.51.4"},"reference-count":6,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers\u2019 attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned.<\/jats:p>","DOI":"10.1136\/dtb.2020.000021","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T15:19:29Z","timestamp":1585667969000},"page":"69-69","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["EMA advice on the use of NSAIDs for Covid-19"],"prefix":"10.1136","volume":"58","member":"239","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"2025082701214530000_58.5.69.1","unstructured":"European Medicines Agency . EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19 [online]. 2020. Available: https:\/\/www.ema.europa.eu\/en\/news\/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19 [Accessed 24 March 2020]."},{"key":"2025082701214530000_58.5.69.2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025082701214530000_58.5.69.3","unstructured":"Roth M . Ibuprofen and COVID-19 [online]. 2020. Available: https:\/\/www.unibas.ch\/en\/News-Events\/News\/Uni-Research\/Ibuprofen-and-COVID-19-Setting-the-record-straight.html [Accessed 24 March 2020]."},{"key":"2025082701214530000_58.5.69.4","unstructured":"Medicines and Healthcare products Regulatory Agency . Ibuprofen use and Coronavirus (COVID-19) [online]. 2020. Available: https:\/\/www.gov.uk\/government\/news\/ibuprofen-use-and-covid19coronavirus [Accessed 24 March 2020]."},{"key":"2025082701214530000_58.5.69.5","doi-asserted-by":"publisher","DOI":"10.1038\/nri3843"},{"key":"2025082701214530000_58.5.69.6","unstructured":"Powis S . Message for all clinical staff: anti-inflammatory medications [online]. Available: https:\/\/www.cas.mhra.gov.uk\/ViewandAcknowledgment\/ViewAlert.aspx?AlertID=103001 [Accessed 24 March 2020]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2020.000021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:21:57Z","timestamp":1756282917000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2020.000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":6,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,4,29]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/dtb.2020.000021"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2020.000021","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]}}}